Pfizer requests approval for kids’ booster
Pfizer and BioNTech have requested that the Food and Drug Administration authorize a COVID-19 booster shot for children ages 5-11. The companies announced Tuesday they submitted for an emergency use authorization from the FDA after a study showed a strong immune response to a booster shot among healthy children in that age group.






